Life Science Consulting Translating Innovation into Market Success Our life science consulting expertise extends to medical device, pharmac
Selecting the Life Science Project with the Highest ROI Potential for a Platform Technology
Our life science consulting expertise extends to medical device, pharmaceutical and biotech companies involved in technology, medication and biologic products to cure. treat, and prevent a variety of diseases. The opportunities to capture revenues in these markets are significant. In 2022, the global market for medical devices was $4898 USD projected to grow to $719B USD by 2029 at a CAGR of 5.5% during the forecast timeline. The pharmaceutical market is triple that size with a CAGR of 9.1%. Patient care and management require continued commitment and innovation development, especially as the population profile of most countries is aging. According to the World Health Organization, by 2030, one in every six people on the planet will be 60 years or older, an age when more healthcare services are required.
We work with life science and medical technology companies who create life changing innovation to allow people to live longer, healthier and more productive lives. companies develop, manufacture, distribute and support the technologies, devices, equipment, diagnostic tests, and health information systems that are transforming health care through earlier disease detection, less-invasive procedures, and more effective treatments.
The clinical areas of medical technology we are involved in include neurostimulation, oncology, orthobiologics, minimally invasive surgery, robotic-assisted technology. orthopedics including spine, cardiovascular, gastroenterology, dermatology, wound closure, women's and men's health, energy-based therapeutics and diagnostics and others. Strategy Inc. also is involved in mobile health applications and Al driven technologies.